| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 09/15/2021 |
3. Issuer Name and Ticker or Trading Symbol
Definitive Healthcare Corp. [ DH ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Class A Common Stock | 66,093,582(1) | I | See notes(2)(3)(4) |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
1. Name and Address of Reporting Person*
(Street)
| ||||||||||||
1. Name and Address of Reporting Person*
(Street)
| ||||||||||||
1. Name and Address of Reporting Person*
(Street)
| ||||||||||||
1. Name and Address of Reporting Person*
(Street)
| ||||||||||||
1. Name and Address of Reporting Person*
(Street)
| ||||||||||||
1. Name and Address of Reporting Person*
(Street)
| ||||||||||||
1. Name and Address of Reporting Person*
(Street)
| ||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
| Explanation of Responses: |
| 1. See Exhibit 99.1 for text of footnote (1). |
| 2. See Exhibit 99.1 for text of footnote (2). |
| 3. See Exhibit 99.1 for text of footnote (3). |
| 4. See Exhibit 99.1 for text of footnote (4). |
| Remarks: |
| Christopher Egan, a Managing Partner of Advent and Lauren Young, a Managing Director of Advent (together, the "Advent Directors"), each serve on the board of directors of the Issuer, and have been deputized to represent the Reporting Persons on the board of directors. By virtue of the Advent Directors' representation, for purposes of Section 16 of the Securities Exchange Act of 1934, each of the Reporting Persons may be deemed directors by deputization of the Issuer. The Advent Directors have filed separate Section 16 reports disclosing securities of the Issuer that they may be deemed to beneficially own for Section 16 purposes. Exhibit 99.1 (Footnotes to Form 3) and Exhibit 99.2 (Signatures and Joint Filer Information) are incorporated by reference. Form 1 of 5: This Form 3 is the first of five Forms 3 being filed relating to the same event. The Form 3 has been split into multiple filings because there are more than 10 Reporting Persons total, and the SEC's EDGAR filing system limits a single Form 3 to a maximum of 10 Reporting Persons. Each Form 3 will be filed by Designated Filer Advent International Corporation. |
| ADVENT INTERNATIONAL CORPORATION, By: /s/ Neil Crawford, Name: Neil Crawford, Title: Director, Fund Administration | 09/15/2021 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||
Exhibit 99.1
Footnotes to Form 3
|
(1)
|
This amount excludes an aggregate of 855,447 shares of Class A common stock that the Reporting Persons have irrevocably agreed to sell to the Issuer
upon closing of the initial public offering (“IPO”), at a price per share equal to the IPO price of the Class A common stock minus underwriting discounts. This transaction was approved by the board of directors of the Issuer for purposes
of Rule 16b-3 of the Securities Exchange Act of 1934, as amended.
|
|
(2)
|
Advent International Corporation (“Advent”) manages funds that collectively own 66,093,582 shares of Class A common stock of the Issuer, which are
represented as follows: (i) 17,957,220 shares are held directly by Advent International GPE IX Limited Partnership (“GPE-IX LP”), (ii)
3,558,302 shares are held directly Advent International GPE IX-B Limited Partnership (“GPE IX-B LP”), (iii) 1,477,168 shares are held directly by Advent International GPE IX-C Limited Partnership (“GPE IX-C LP”), (iv) 1,549,835 shares
are held directly by Advent International GPE IX-F Limited Partnership (“GPE IX-F LP”), (v) 5,099,704 shares are held directly by Advent International GPE IX-G Limited Partnership (“GPE IX-G LP”), (vi) 5,749,650 shares are held directly
by Advent International GPE IX-H Limited Partnership (“GPE IX-H LP”), (vii) 3,256,725 shares are held directly by Advent International GPE IX-I Limited Partnership (“GPE IX-I LP”), (viii) 5,280,409 shares are held directly by Advent
International GPE IX-A SCSP (“GPE IX-A SCSP”), (ix) 1,123,938 shares are held directly by Advent International GPE IX-D SCSP (“GPE IX-D SCSP”), (x) 2,284,139 shares are held directly by Advent International GPE IX-E SCSP (“GPE IX-E
SCSP”), (xi) 103,183 shares are held directly by Advent International GPE IX Strategic Investors SCSP (“GPE IX Strategic Investors SCSP”), (xii) 58,929 shares are held directly by Advent Partners GPE IX Limited Partnership (“AP GPE IX LP”), (xiii) 136,271 shares are held directly by Advent Partners GPE IX-A Limited Partnership (“AP GPE IX-A LP”), (xiv) 340,039 shares are held directly by Advent Partners GPE IX Cayman Limited Partnership (“AP GPE IX Cayman LP”), (xv) 57,319 shares are held directly by Advent Partners GPE IX-A Cayman Limited Partnership (“AP GPE IX-A Cayman LP”), (xvi) 951,590 shares are
held directly by Advent Partners GPE IX-B Cayman Limited Partnership (“AP GPE IX-B Cayman LP”), (xvii) 4,044,378 shares are held
directly by Advent Global Technology Limited Partnership (“Global Technology LP”), (xviii) 3,147,454 shares are held directly by Advent Global Technology-B Limited Partnership (“Global Technology-B LP”), (xix) 1,704,132 shares are held
directly by Advent Global Technology-C Limited Partnership (“Global Technology-C LP”), (xx) 2,040,196 shares are held directly by Advent Global Technology-D Limited Partnership (“Global Technology-D LP”), (xxi) 1,996,436 shares are held
directly by Advent Global Technology-A SCSP (“Global Technology-A SCSP”), (xxii) 6,345 shares are held directly by Advent Partners AGT Limited Partnership (“AGT LP”), (xxiii) 28,990 shares are held directly by Advent Partners AGT-A
Limited Partnership (“AGT-A LP”), (xxiv) 363,158 shares are held directly by Advent Partners AGT Cayman Limited Partnership (“AGT Cayman LP”), (xxv) 32,347 shares are held directly by Advent Global Technology Strategic Investors Limited
Partnership (“AGT Strategic Investors LP”) and (xxvi) 3,745,725 shares are held directly by Sunley House Capital Master Limited Partnership (“Sunley House Master Fund”).
|
|
(3)
|
GPE IX GP Limited Partnership is the general partner
of GPE-IX LP, GPE IX-B LP, GPE IX-C LP, GPE IX-F LP, GPE IX-G LP, GPE IX-H LP and GPE IX-I LP. GPE IX GP S.à r.l. is the general partner of GPE IX-A SCSP, GPE IX-D SCSP, GPE IX-E SCSP and GPE IX Strategic Investors SCSP. AP GPE IX GP
Limited Partnership is the general partner of AP GPE IX LP, AP GPE IX-A LP, AP GPE IX Cayman LP, AP GPE IX-A Cayman LP and AP GPE IX-B Cayman LP. Advent Global Technology GP Limited Partnership is the general partner of Global
Technology LP, Global Technology-B LP, Global Technology-C LP and Global Technology-D LP. Advent Global Technology GP S.à r.l. is the general partner of Technology-A SCSP. AP AGT GP Limited Partnership is the general partner of AGT LP,
AGT-A LP, AGT Cayman LP and AGT Strategic Investors LP. Advent International GPE IX, LLC is the general partner of GPE IX GP Limited Partnership, AP GPE IX GP Limited Partnership and GPE IX GP S.à r.l. Advent Global Technology LLC is
the general partner of Advent Global Technology GP Limited Partnership, Advent Global Technology GP S.à r.l. and AP AGT GP Limited Partnership. Sunley House Capital GP LP (“Sunley House GP LP”), as general partner of Sunley House Master
Fund, Sunley House Capital GP LLC (“Sunley House GP LLC”), as general partner of Sunley House GP LP, and Sunley House Capital Management LLC (“Sunley House Manager”), as investment manager to Sunley House Master Fund, may be deemed to
beneficially own the shares held directly by Sunley House Master Fund. Advent is the manager of Advent International GPE IX, LLC and Advent Global Technology LLC and is the sole member of both Sunley House GP LLC and Sunley House
Manager. Investors in the Sunley House Master Fund invest in one or more of the following feeder funds: Sunley House Capital Fund LP, Sunley House Capital Limited Partnership, Sunley House Capital Fund Ltd. and Sunley House Capital Ltd.
(collectively, the “Sunley House Feeder Funds”), which are the limited partners of the Sunley House Master Fund. The Sunley House Feeder Funds have ownership interests in the Sunley House Master Fund, but none of the Sunley House Feeder
Funds owns shares directly and none has voting or dispositive power over the shares held directly by the Sunley House Master Fund.
|
|
(4)
|
Each Reporting Person disclaims Section 16 beneficial ownership of the shares reported herein except to the extent of its
pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of any of the reported shares for purposes of Section 16 or any other purpose.
|
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE IX Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT INTERNATIONAL GPE IX LIMITED PARTNERSHIP
|
||
|
By:
|
GPE IX GP Limited Partnership, its General Partner
|
|
|
By:
|
Advent International GPE IX, LLC, its General Partner
|
|
|
By:
|
Advent International Corporation, its Manager
|
|
|
By: /s/ Neil Crawford
|
||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE IX-B Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT INTERNATIONAL GPE IX-B LIMITED PARTNERSHIP
|
||
|
By:
|
GPE IX GP Limited Partnership, its General Partner
|
|
|
By:
|
Advent International GPE IX, LLC, its General Partner
|
|
|
By:
|
Advent International Corporation, its Manager
|
|
|
By: /s/ Neil Crawford
|
||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE IX-C Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT INTERNATIONAL GPE IX-C LIMITED PARTNERSHIP
|
||
|
By:
|
GPE IX GP Limited Partnership, its General Partner
|
|
|
By:
|
Advent International GPE IX, LLC, its General Partner
|
|
|
By:
|
Advent International Corporation, its Manager
|
|
|
By: /s/ Neil Crawford
|
||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE IX-F Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT INTERNATIONAL GPE IX-F LIMITED PARTNERSHIP
|
||
|
By:
|
GPE IX GP Limited Partnership, its General Partner
|
|
|
By:
|
Advent International GPE IX, LLC, its General Partner
|
|
|
By:
|
Advent International Corporation, its Manager
|
|
|
By: /s/ Neil Crawford
|
||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE IX-G Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT INTERNATIONAL GPE IX-G LIMITED PARTNERSHIP
|
||
|
By:
|
GPE IX GP Limited Partnership, its General Partner
|
|
|
By:
|
Advent International GPE IX, LLC, its General Partner
|
|
|
By:
|
Advent International Corporation, its Manager
|
|
|
By: /s/ Neil Crawford
|
||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE IX-H Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT INTERNATIONAL GPE IX-H LIMITED PARTNERSHIP
|
||
|
By:
|
GPE IX GP Limited Partnership, its General Partner
|
|
|
By:
|
Advent International GPE IX, LLC, its General Partner
|
|
|
By:
|
Advent International Corporation, its Manager
|
|
|
By: /s/ Neil Crawford
|
||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE IX-I Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT INTERNATIONAL GPE IX-I LIMITED PARTNERSHIP
|
||
|
By:
|
GPE IX GP Limited Partnership, its General Partner
|
|
|
By:
|
Advent International GPE IX, LLC, its General Partner
|
|
|
By:
|
Advent International Corporation, its Manager
|
|
|
By: /s/ Neil Crawford
|
||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE IX-A SCSP
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT INTERNATIONAL GPE IX-A SCSP
|
|||
|
By:
|
GPE IX GP S.à r.l., its General Partner
|
||
|
By:
|
Advent International GPE IX, LLC, its General Partner
|
/s/ Justin Nuccio
|
|
|
By:
|
Advent International Corporation, its Manager
|
Justin Nuccio, Manager
|
|
|
By: /s/ Neil Crawford
|
|||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE IX-D SCSP
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT INTERNATIONAL GPE IX-D SCSP
|
|||
|
By:
|
GPE IX GP S.à r.l., its General Partner
|
||
|
By:
|
Advent International GPE IX, LLC, its General Partner
|
/s/ Justin Nuccio
|
|
|
By:
|
Advent International Corporation, its Manager
|
Justin Nuccio, Manager
|
|
|
By: /s/ Neil Crawford
|
|||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE IX-E SCSP
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT INTERNATIONAL GPE IX-E SCSP
|
|||
|
By:
|
GPE IX GP S.à r.l., its General Partner
|
||
|
By:
|
Advent International GPE IX, LLC, its General Partner
|
/s/ Justin Nuccio
|
|
|
By:
|
Advent International Corporation, its Manager
|
Justin Nuccio, Manager
|
|
|
By: /s/ Neil Crawford
|
|||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE IX Strategic Investors SCSP
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT INTERNATIONAL GPE IX STRATEGIC INVESTORS SCSP
|
|||
|
By:
|
GPE IX GP S.à r.l., its General Partner
|
||
|
By:
|
Advent International GPE IX, LLC, its General Partner
|
/s/ Justin Nuccio
|
|
|
By:
|
Advent International Corporation, its Manager
|
Justin Nuccio, Manager
|
|
|
By: /s/ Neil Crawford
|
|||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Partners GPE IX Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT PARTNERS GPE IX LIMITED PARTNERSHIP
|
||
|
By:
|
AP GPE IX Limited Partnership, its General Partner
|
|
|
By:
|
Advent International GPE IX, LLC, its General Partner
|
|
|
By:
|
Advent International Corporation, its Manager
|
|
|
By: /s/ Neil Crawford
|
||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Partners GPE IX-A Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT PARTNERS GPE IX-A LIMITED PARTNERSHIP
|
||
|
By:
|
AP GPE IX Limited Partnership, its General Partner
|
|
|
By:
|
Advent International GPE IX, LLC, its General Partner
|
|
|
By:
|
Advent International Corporation, its Manager
|
|
|
By: /s/ Neil Crawford
|
||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Partners GPE IX Cayman Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT PARTNERS GPE IX CAYMAN LIMITED PARTNERSHIP
|
||
|
By:
|
AP GPE IX Limited Partnership, its General Partner
|
|
|
By:
|
Advent International GPE IX, LLC, its General Partner
|
|
|
By:
|
Advent International Corporation, its Manager
|
|
|
By: /s/ Neil Crawford
|
||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Partners GPE IX-A Cayman Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT PARTNERS GPE IX-A CAYMAN LIMITED PARTNERSHIP
|
||
|
By:
|
AP GPE IX Limited Partnership, its General Partner
|
|
|
By:
|
Advent International GPE IX, LLC, its General Partner
|
|
|
By:
|
Advent International Corporation, its Manager
|
|
|
By: /s/ Neil Crawford
|
||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Partners GPE IX-B Cayman Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT PARTNERS GPE IX-B CAYMAN LIMITED PARTNERSHIP
|
||
|
By:
|
AP GPE IX Limited Partnership, its General Partner
|
|
|
By:
|
Advent International GPE IX, LLC, its General Partner
|
|
|
By:
|
Advent International Corporation, its Manager
|
|
|
By: /s/ Neil Crawford
|
||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
GPE IX GP Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
GPE IX GP LIMITED PARTNERSHIP
|
||
|
By:
|
Advent International GPE IX, LLC, its General Partner
|
|
|
By:
|
Advent International Corporation, its Manager
|
|
|
By: /s/ Neil Crawford
|
||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
GPE IX GP S.à.r.l.
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
GPE IX GP S.À.R.L.
|
|||
|
By:
|
Advent International GPE IX, LLC, its General Partner
|
/s/ Justin Nuccio
|
|
|
By:
|
Advent International Corporation, its Manager
|
Justin Nuccio, Manager
|
|
|
By: /s/ Neil Crawford
|
|||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
AP GPE IX GP Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
AP GPE IX GP LIMITED PARTNERSHIP
|
||
|
By:
|
Advent International GPE IX, LLC, its General Partner
|
|
|
By:
|
Advent International Corporation, its Manager
|
|
|
By: /s/ Neil Crawford
|
||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent International GPE IX, LLC
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT INTERNATIONAL GPE IX, LLC
|
||
|
By:
|
Advent International Corporation, its Manager
|
|
|
By: /s/ Neil Crawford
|
||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Global Technology Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT GLOBAL TECHNOLOGY LIMITED PARTNERSHIP
|
||
|
By:
|
Advent Global Technology GP Limited Partnership, its General Partner
|
|
|
By:
|
Advent Global Technology LLC, its General Partner
|
|
|
By:
|
Advent International Corporation, its Manager
|
|
|
By: /s/ Neil Crawford
|
||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Global Technology-B Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT GLOBAL TECHNOLOGY-B LIMITED PARTNERSHIP
|
||
|
By:
|
Advent Global Technology GP Limited Partnership, its General Partner
|
|
|
By:
|
Advent Global Technology LLC, its General Partner
|
|
|
By:
|
Advent International Corporation, its Manager
|
|
|
By: /s/ Neil Crawford
|
||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Global Technology-C Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT GLOBAL TECHNOLOGY-C LIMITED PARTNERSHIP
|
||
|
By:
|
Advent Global Technology GP Limited Partnership, its General Partner
|
|
|
By:
|
Advent Global Technology LLC, its General Partner
|
|
|
By:
|
Advent International Corporation, its Manager
|
|
|
By: /s/ Neil Crawford
|
||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Global Technology-D Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT GLOBAL TECHNOLOGY-D LIMITED PARTNERSHIP
|
||
|
By:
|
Advent Global Technology GP Limited Partnership, its General Partner
|
|
|
By:
|
Advent Global Technology LLC, its General Partner
|
|
|
By:
|
Advent International Corporation, its Manager
|
|
|
By: /s/ Neil Crawford
|
||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Global Technology-A SCSP
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT GLOBAL TECHNOLOGY-A SCSP
|
|||
|
By:
|
Advent Global Technology GP S.à.r.l., its General Partner
|
||
|
By:
|
Advent Global Technology LLC, its General Partner
|
/s/ Justin Nuccio
|
|
|
By:
|
Advent International Corporation, its Manager
|
Justin Nuccio, Manager
|
|
|
By: /s/ Neil Crawford
|
|||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Partners AGT Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT PARTNERS AGT LIMITED PARTNERSHIP
|
||
|
By:
|
AP AGT GP Limited Partnership, its General Partner
|
|
|
By:
|
Advent Global Technology LLC, its General Partner
|
|
|
By:
|
Advent International Corporation, its Manager
|
|
|
By: /s/ Neil Crawford
|
||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Partners AGT-A Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT PARTNERS AGT-A LIMITED PARTNERSHIP
|
||
|
By:
|
AP AGT GP Limited Partnership, its General Partner
|
|
|
By:
|
Advent Global Technology LLC, its General Partner
|
|
|
By:
|
Advent International Corporation, its Manager
|
|
|
By: /s/ Neil Crawford
|
||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Partners AGT Cayman Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT PARTNERS AGT CAYMAN LIMITED PARTNERSHIP
|
||
|
By:
|
AP AGT GP Limited Partnership, its General Partner
|
|
|
By:
|
Advent Global Technology LLC, its General Partner
|
|
|
By:
|
Advent International Corporation, its Manager
|
|
|
By: /s/ Neil Crawford
|
||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Global Technology Strategic Investors Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT GLOBAL TECHNOLOGY STRATEGIC INVESTORS LIMITED PARTNERSHIP
|
||
|
By:
|
AP AGT GP Limited Partnership, its General Partner
|
|
|
By:
|
Advent Global Technology LLC, its General Partner
|
|
|
By:
|
Advent International Corporation, its Manager
|
|
|
By: /s/ Neil Crawford
|
||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Global Technology GP Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT GLOBAL TECHNOLOGY GP LIMITED PARTNERSHIP
|
||
|
By:
|
Advent Global Technology LLC, its General Partner
|
|
|
By:
|
Advent International Corporation, its Manager
|
|
|
By: /s/ Neil Crawford
|
||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Global Technology GP S.à.r.l.
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT GLOBAL TECHNOLOGY GP S.À.R.L.
|
|||
|
By:
|
Advent Global Technology LLC, its General Partner
|
/s/ Justin Nuccio
|
|
|
By:
|
Advent International Corporation, its Manager
|
Justin Nuccio, Manager
|
|
|
By: /s/ Neil Crawford
|
|||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
AP AGT GP Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
AP AGT GP LIMITED PARTNERSHIP
|
||
|
By:
|
Advent Global Technology LLC, its General Partner
|
|
|
By:
|
Advent International Corporation, its Manager
|
|
|
By: /s/ Neil Crawford
|
||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Advent Global Technology LLC
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
ADVENT GLOBAL TECHNOLOGY LLC
|
||
|
By:
|
Advent International Corporation, its Manager
|
|
|
By: /s/ Neil Crawford
|
||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Sunley House Capital Master Limited Partnership
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
SUNLEY HOUSE CAPITAL MASTER LIMITED PARTNERSHIP
|
||
|
By:
|
Sunley House Capital GP LP, its General Partner
|
|
|
By:
|
Sunley House Capital GP LLC, its General Partner
|
|
|
By:
|
Advent International Corporation, its Sole Member
|
|
|
By: /s/ Neil Crawford
|
||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Sunley House Capital GP LP
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
SUNLEY HOUSE CAPITAL GP LP
|
||
|
By:
|
Sunley House Capital GP LLC, its General Partner
|
|
|
By:
|
Advent International Corporation, its Sole Member
|
|
|
By: /s/ Neil Crawford
|
||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Sunley House Capital GP LLC
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
SUNLEY HOUSE CAPITAL GP LLC
|
||
|
By:
|
Advent International Corporation, its Sole Member
|
|
|
By: /s/ Neil Crawford
|
||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date
Joint Filer Information
|
Name of Joint Filer:
|
Sunley House Capital Management LLC
|
|
Address of Joint Filer:
|
c/o Advent International Corporation
|
|
Prudential Tower, 800 Boylston Street, Suite 3300
|
|
|
Boston, MA 02199-8069
|
|
|
Relationship of Joint Filer to Issuer:
|
10% Owner, Director
|
|
Issuer Name and Ticker or Trading Symbol:
|
Definitive Healthcare Corp. [ DH ]
|
Date of Event Requiring Statement
|
(Month/Day/Year):
|
September 15, 2021
|
|
Designated Filer:
|
Advent International Corporation
|
Signature:
|
SUNLEY HOUSE CAPITAL MANAGEMENT LLC
|
||
|
By:
|
Advent International Corporation, its Sole Member
|
|
|
By: /s/ Neil Crawford
|
||
|
Name:
|
Neil Crawford
|
|
|
Title:
|
Director, Fund Administration
|
September 15, 2021
Date